Drug Development for Neglected Diseases
From PHM Oz
(Difference between revisions)
DavidLegge (Talk | contribs) |
DavidLegge (Talk | contribs) |
||
| Line 9: | Line 9: | ||
WHO Commission on Intellectual Property Rights, Innovation and Public Health [[http://www.who.int/intellectualproperty/report/en/]] | WHO Commission on Intellectual Property Rights, Innovation and Public Health [[http://www.who.int/intellectualproperty/report/en/]] | ||
| + | Medical Innovation Prize Fund Proposal (James Love)[[http://www.cptech.org/ip/health/prizefund/]] | ||
[[Intellectual Property and Pharmaceuticals|Back to IP home]] | [[Intellectual Property and Pharmaceuticals|Back to IP home]] | ||
Revision as of 03:47, 9 July 2007
orphan diseases
Drugs for Neglected Diseases Initiative (DNDI)[[1]]
under-investment in the development of drugs for neglected diseases
WHO Commission on Intellectual Property Rights, Innovation and Public Health [[2]]
Medical Innovation Prize Fund Proposal (James Love)[[3]]
